University of Portsmouth
port.ac.ukTotal trials
32
Active
1
Phase 3
0
Total enrollment
61,516
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Cystic Fibrosis3
- Cystic Fibrosis-related Diabetes2
- End Stage Renal Disease2
- Aging2
- Diabetes Mellitus, Type 22
- Type2 Diabetes2
- Dental Erosion2
- Type 2 Diabetes2
Frequently asked questions about University of Portsmouth
- How many clinical trials does University of Portsmouth have on ClinicalTrials.gov?
- University of Portsmouth is listed as the lead sponsor on 32 clinical trials in ClinicalTrials.gov, 1 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Portsmouth's trials are in Phase 3?
- 0 of University of Portsmouth's trials are in Phase 3.
- What therapeutic areas does University of Portsmouth focus on?
- University of Portsmouth's most-studied conditions on ClinicalTrials.gov are Cystic Fibrosis, Cystic Fibrosis-related Diabetes, End Stage Renal Disease, Aging, Diabetes Mellitus, Type 2.